We found that there was no significant difference in the numbers of circulating CD4+ T cells among these groups of subjects and CD4+CD25−Foxp3+ and CD4+CD25+Foxp3+ Tregs between the CHB and CHC patients in this population (Figure 2A and B). This evidence concerns the gene FOXP3 and cryohydrocytosis.